Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting clinically relevant and more informative adverse event information in clinical trial publications.|
|Full bibliographic reference||Lineberry N, Berlin JA, Mansi B, Glasser S, Berkwits M, Klem C, Bhattacharya A, Citrome L, Enck R, Fletcher J, Haller D, Chen TT, Laine C. Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective.
|Study design||Clinical trials, Experimental studies|
|Applies to the whole report or to individual sections of the report?||Harms/adverse effects/safety data|
|Record last updated on||October 11, 2016|
|Clinical practice guidelines||AGREE||RIGHT|
|Animal pre-clinical studies||ARRIVE|
|Quality improvement studies||SQUIRE|
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.
Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.